| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |